CD33 and neoplasm: In order to evaluate the in vivo anti-tumor activity of 123b-33bcCAR T-cells, we developed two mouse models with either luciferase-expressing MOLM13 (CD123+CD33+) or U937 (CD123−CD33+) cells to induce fluorescence visible tumor formation (Fig. 4a, d).